InvestorsHub Logo
Followers 49
Posts 4907
Boards Moderated 1
Alias Born 01/05/2005

Re: None

Thursday, 03/08/2007 10:25:36 AM

Thursday, March 08, 2007 10:25:36 AM

Post# of 1171
Today's Wall Street Journal (page D1) discusses the new generation of drug-eluting cardiac stents coming from Boston Scientific, Medtronic, Johnson & Johnson and Abbott Labs awaiting FDA approval. Upon the FDA's OK, these more advanced, safer stents should result in new demand for SOTK's drug coating applications equipment.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.